Why the study?
Cardiovascular autonomic neuropathy (CAN) may affect the clinical course of SLE, leading to reduced quality of life, but its characteristics and association with health-related quality of life in SLE remained to be determined.
Is cardiovascular autonomic neuropathy more prevalent in patients with systemic lupus erythematosus and does it associate with reduced health-related quality of life?
Is cardiovascular autonomic neuropathy more prevalent in patients with systemic lupus erythematosus and does it associate with reduced health-related quality of life?
Cardiovascular autonomic neuropathy is highly prevalent in patients with systemic lupus erythematosus and is significantly associated with impaired physical health-related quality of life.
Answers are grounded in this paper and cite their sources.
CAN may reduce HRQoL in SLE; leaves open whether routine autonomic testing improves management or outcomes.
OBJECTIVES: Cardiovascular autonomic neuropathy (CAN) may affect the clinical course of SLE leading to reduced quality of life. CAN is assessed by heart rate variability (HRV) measures and cardiovascular autonomic reflex tests (CARTs). In patients with SLE, we aimed to determine the characteristics of CAN and if CAN associates with health-related quality of life (HRQoL). METHODS: Patients with SLE and healthy controls (HCs) were CAN tested with 5 min HRV and three CARTs to determine parameters reflecting parasympathetic and mixed sympathetic-parasympathetic function. Subjects were classified as having no, early or definitive CAN by having none, one or more than one abnormal CART, respectively. HRQoL as determined by the Short Form 12 (SF-12) was assessed in SLE. RESULTS: Of 111 patients with SLE, 92 answered the SF-12 and 54 were matched with 54 HCs for characterisation of CAN. Definitive CAN was present in 24.1% (95% CI 15% to 37%) patients with SLE and 1.9% (95% CI 0.3% to 9.8%) HCs (OR 16.8, 95% CI 2.1 to 133.8, p=0.008). The corresponding prevalences of any CAN were 53.7% (95% CI 41% to 66%) and 22.6% (95% CI 13% to 35%). SLE patients with definitive CAN showed signs of mixed sympathetic-parasympathetic dysfunction, whereas patients without CAN primarily presented with impaired parasympathetic activity. Signs of parasympathetic as well as sympathetic-parasympathetic dysfunction were associated with low physical SF-12 component score (all: β>0.211, p<0.05). The mental SF-12 component score was not associated with any CAN indices. CONCLUSIONS: CAN was a frequent finding in SLE and associated to self-report on impaired physical HRQoL. Even patients without CAN showed signs of impaired parasympathetic function compared with controls.
No takes yet. Share an insight, caveat, or question.
Zinglersen et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: